An injectable polyethylene glycol-crosslinked albumin gel (AG) supplemented with hyaluronic acid as a matrix for autologous chondrocyte implantation was evaluated with regard to its impact on angiogenesis. Healthy articular cartilage and intervertebral discs (IVD) are devoid of blood vessels, whereas pathological blood vessel formation augments degeneration of both theses tissues. In contrast to human endothelial cells, primary human articular chondrocytes encapsulated in the AG retained their viability. Endothelial cells did not adhere to the gel surface to a significant extent nor did they proliferate in vitro. The AG did not release any diffusible toxic components. Contrary to Matrigel TM employed as positive control, the AG prevented endothelial chemoinvasion in Transwell filter assays even in the presence of a chemotactic gradient of vascular endothelial growth factor. In ovo, the AG exhibited a barrier function for blood vessels of the chick chorioallantoic membrane. Subcutaneous implantation of human IVD chondrocytes enclosed in the albumin gel into immunodeficient mice revealed a complete lack of angiogenesis inside the gel after two weeks. At the same time, the IVD chondrocytes within the gel remained vital and displayed a characteristic gene expression pattern as judged from aggrecan, collagen type I and type II mRNA levels. In summary, aiming at articular cartilage and IVD regeneration the albumin gel promises to be a beneficial implant matrix for chondrocytes simultaneously exhibiting non-permissive properties for adverse endothelial cells.
Introduction
Articular cartilage defects or intervertebral disc (IVD) degeneration call for an efficient early-onset long-term therapy to postpone or prevent radical surgical interventions such as total joint replacement or spinal fusion. The implantation of autologous articular chondrocytes or IVD chondrocytes within a biomaterial into the degenerated tissue is thought to overcome the reduced self-regeneration capacity (Hunziker, 1999; Roughley, 2004; Vinatier et al., 2009) of these tissues at least partially (Hunziker, 1999; Paesold et al., 2007) .
The choice of an ideal biomaterial is crucial for successful regeneration. In general, a biomaterial should mimic the microenvironment of the desired tissue (Anderson et al., 2005) . As reviewed by Chan and Leong (2008) , biomaterials should furthermore be bioactive, cyto-and tissue compatible, should provide mechanical support and void volume for tissue formation and remodelling. For many applications resorption of the biomaterial is advantageous as well. Many biomaterials have been investigated for both autologous chondrocyte implantation and implantation of IVD chondrocytes (Anderson et al., 2005; Vinatier et al., 2009) . One obstacle facing pre-made porous scaffolds, which are commonly used for articular cartilage and IVD tissue engineering, is co-morbidity from an occasionally highly invasive implantation procedure (Chan and Leong, 2008) . By contrast, injectable hydrogels can be transferred minimally invasive into the defect via a small incision (Boyd and Carter, 2006; Vinatier et al., 2009) . The liquid hydrogels can integrate even into an irregularly shaped defect before solidification takes place (Boyd and Carter, 2006) . Another advantage of hydrogels is the high water content resembling the conditions in native cartilage (Sontjens et al., 2006) . Besides these biological reflections, a rapid approval for clinical application is desirable. Medical prescription formulations of human serum albumin have already drug status illustrating one main rationale for the choice of albumin as major gel component in our hydrogel.
A special feature of healthy mature articular cartilage and the IVD is the absence of blood vessels. However, blood vessels may appear during pathophysiological conditions (Ballara et al., 1999; Huber et al., 2000) -a fact, which we propose should be considered when designing an optimized biomaterial for articular cartilage and IVD regeneration.
Inflammation and angiogenesis are processes being involved in the progression of osteoarthritis (OA) (Ballara et al., 1999) . In joints of OA-patients, the inflammatory cytokine interleukin-1 (IL-1) not only induces the expression of matrix metalloproteinases (MMPs), which 25 www.ecmjournal.org B Scholz et al. Angiogenesis suppression in hydrogel are responsible for cartilage matrix degradation, but also stimulates chondrocytes to express vascular endothelial growth factor (VEGF). This pro-angiogenic growth factor leads to the penetration of blood vessels originating from the subchondral bone into the cartilage (Bonnet and Walsh, 2005) which causes the subsequent ingrowth of bony outgrowths (Ballara et al., 1999) and nerve supply by sensory neurons representing a major cause for pain (Ashraf and Walsh, 2008) . As described for articular cartilage, innervation of the IVD accompanied by pain is probably also dependent on angiogenesis (Johnson et al., 2001; Paesold et al., 2007) and angiogenesis seems to enhance degeneration of the IVD after herniation (Ballara et al., 1999; Haro et al., 2002) . In conclusion, angiogenesis also seems to augment IVD degeneration and pain.
We propose a biomaterial which inhibits the ingrowth of blood vessels after autologous chondrocyte implantation as being advantageous for the regeneration of articular cartilage and the IVD. Therefore, we investigated the influence of an injectable hydrogel for articular cartilage and IVD regeneration, which already has obtained a pharmaceutical product license and is currently investigated in a Phase I clinical trial, on blood vessel formation.
Materials and Methods

Materials
Penicillin-G and streptomycin were purchased from PAA (Pasching, Austria). 4',6-diamidino-2-phenylindole (DAPI), gelatin, propidium iodide, Rose Bengal dye as well as resazurin were obtained from Sigma-Aldrich (Steinheim, Germany). Vascular endothelial growth factor (VEGF) was from PeproTech (recombinant human VEGF165, Rocky Hill, NJ, USA). Acetylated low-density lipoprotein labelled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate (DiI-Ac-LDL, Biomedical Technologies, Stoughton, MA, USA), calcein and Oregon Green @ 488 phalloidin (Molecular Probes, Eugene, OR, USA) were also used. Matrigel TM was purchased from Becton Dickinson (Heidelberg, Germany). Haematoxylin, eosin G and Coomassie ® Brilliant Blue were obtained from Merck (Darmstadt, Germany).
Albumin gel
Activated sheep maleimido-albumin or activated human maleimido-albumin, hyaluronic acid and cell culture medium without supplements and without serum were used as basis for the albumin gel (AG). Cross-linkage was achieved through a specific thio-polyethylene glycol (HS-PEG-SH; Rapp Polymere GmbH, Tubingen, Germany) spacer via Michael reaction of a maleimide-group to a SHgroup. (Pending patents number: PCT/EP2008/005643, DPMA 10 2008 008 071.3). Unless otherwise stated, sheep serum albumin was utilized for the experiments.
For the production of maleimido-albumin, 250 mg of human or sheep serum albumin (Sigma-Aldrich) were dissolved in 5 ml 1 M sodium borate (pH 8.2, AppliChem, Darmstadt, Germany). Afterwards 75 μl 260 mM 3-maleimidopropionic acid (Sigma-Aldrich) in PBS/ sodium borate (pH 8.2; 1:1) were added and incubated for 90 min at room temperature. 106 mg 3-maleimidopropionic acid N-hydroxysuccinimide ester (Obiter Research, UrbanaChampaign, IL, USA) were dissolved in 950 μl dimethylformamide (Biosolve, Valkenswaard, Netherlands) and centrifuged in order to pelletize undissolved 3-maleimidopropionic acid Nhydroxysuccinimide ester. 500 μl of the supernatant were added to the albumin solution and incubated for another 60 min at room temperature. Afterwards 500 μl 3 M sodium acetate (pH 4.7) were added. The sample was dialysed against PBS three times on ice for 1h each. The dialysed sample was concentrated to 3.5 ml by ultrafiltration (YM-3 membrane, Millipore, Billerica, MA, USA). By this protocol a functionalization of 15 to 25 maleimide-groups per albumin was achieved. The sample was sterilized by sterile-filtration and stored at -80°C. To prepare 200 μl of the AG, 14 μl maleimido-albumin (43 mM), 106 μl cell culture medium and 40 μl high molecular weight hyaluronic acid (20 mg/ml, Visiol, TRB Chemedica, Munich, Germany) were mixed and incubated for 5 min at room temperature. For different approaches gelatin, VEGF or chondrocytes, as specified below, were added to the indicated cell culture medium. Crosslinkage was achieved by addition of 40 μl HS-PEG-SH (10000 g/mol, 15 mM SH-groups), revealing a 1:1 ratio of maleimidegroups to SH-groups. For the subcutaneous dorsal injection of the AG into the backs of immunodeficient mice, a dualvolume syringe with a Luer-lock mixing adapter and an 18-gauge needle was used which allowed local polymerization. For all other experiments HS-PEG-SH was added to the other components and immediately mixed by pipetting before polymerization started.
Tissue samples
Cartilage tissues were obtained from six osteoarthritis (OA) patients undergoing total endoprosthetic knee replacement. The patients were between 46 and 77 years old, five of them were female and one was male. Only tissue portions with minor signs of degeneration were utilized. Cells isolated from such specimens, displayed no qualitative differences in chondrocyte morphology and no dependency in viability with regard to donor age, gender and the disease stage. Disc tissues were harvested from six patients during spinal fusion surgery. Due to this surgery procedure a clear distinction between nucleus pulposus cells and annulus fibrosus cells was not possible, why these cells were collectively termed "IVD chondrocytes". The patients were between 18 and 61 years old, two of them were female and four were male. All human tissues were obtained from the BG Trauma Clinic in Tubingen (Germany). The studies were approved by the local ethics committee and informed consent was obtained from all individuals participating in the study. 
Isolation of human articular and intervertebral disc chondrocytes
Cell culture
Primary human articular chondrocytes were cultured in DMEM: Ham's F-12 (2:1, Biochrom, Berlin, Germany) supplemented with 10% FCS, 100 U/ml penicillin-G, 100 μg/ml streptomycin and 150 nmol/ml L-ascorbate-2-phosphate in a humidified atmosphere (95% air, 5% CO 2 ) and were used in passage (P) 1 and 2. Primary intervertebral disc (IVD) chondrocytes were cultured in DMEM: Ham's F-12 supplemented with 5% human AB serum (Centre for Clinical Transfusion Medicine, University of Tubingen, Germany), 100 U/ml penicillin-G, 100 μg/ml streptomycin and 150 nmol/ml L-ascorbate-2-phosphate in a humidified atmosphere (95% air, 5% CO 2 ) and were used in P1. Primary human umbilical vein EC (HUVEC) were purchased from PromoCell (Heidelberg, Germany) and cultured in EC growth medium (ECGM) with supplement mix (both PromoCell), 50 U/ml penicillin-G and 50 μg/ml streptomycin in a humidified atmosphere (95% air, 5% CO 2 ). EC were used between P3 and P9. To passage EC, the DetachKit 30 (PromoCell) was used according to manufacturer's instructions. For the characterization of articular chondrocytes within the AG, 2 x 10 5 chondrocytes were embedded in 200 μl AG. Before polymerization, the AG was transferred to a 48 well plate and covered with cell culture medium (see Fig. 1A ). As control, 1.5 x 10 4 chondrocytes were cultured in monolayers in a 48 well plate. For the characterization of HUVEC on AG surfaces, 48 well plates were coated with 100 μl AG. After polymerization, 1.5 x 10 4 HUVEC in ECGM plus supplements were seeded on top of the gel (see Fig. 2A ). As a control, the same number of cells was cultured in 48 well plates coated with 100 μl AG with 0.5% gelatin (AG + gelatin), 100 μl 10 mg/ml Matrigel TM or in gelatin-coated 48 well plates (0.5%). Polymerization of Matrigel TM was achieved by incubation at 37°C for 30 min.
Chondrocyte vitality
Vitality of chondrocytes was examined by live-dead staining with calcein and propidium iodide after one and five days. The cells were incubated with 1 μg/ml calcein for 30 min at 37°C and 5% CO 2 . After 20 min, 3.33 μg/ml propidium iodide was added to the cell culture medium. The AGs were subsequently transferred onto glass slides and squeezed with cover slips. Microscopic analysis was carried out taking optical 3 μm interval Z-stack slices with an Apotome Axio Imager (Carl Zeiss, Göttingen, Germany). Vital and dead cells within the AG were counted in 3 randomly chosen Z-stacks (50 positions). Cells under control conditions were analyzed using an Axiovert (Carl Zeiss, Oberkochen, Germany) microscope by counting vital and dead cells in three randomly chosen microscopic fields. The results are indicated as percent vital cells. Experiments were performed three times in duplicate.
EC adhesion
Cell adhesion of HUVEC was investigated after one and five days by fixation of EC with 2.5% glutaraldehyde for 20 min and subsequent staining of the actin cytoskeleton with Oregon Green @ 488 phalloidin. Furthermore, cell nuclei were visualized with DAPI. For immunofluorescence analysis, cells were washed with PBS and examined by fluorescence microscopy (Axiovert, Carl Zeiss). The number of adherent cells was determined by counting cell nuclei in three randomly selected microscopic fields with the ImageJ (http://rsbweb.nih.gov/ij/) software program. Results are indicated as percent seeded cells. Experiments were performed three times in duplicate.
EC functionality and vitality
Functionality and vitality of HUVEC were determined by the uptake of DiI-Ac-LDL and by staining with calcein and DAPI after one and five days. Cells were incubated with 10 μg/ml DiI-Ac-LDL in ECGM for 4h at 37°C and 5% CO 2 (Voyta et al., 1984) . After 3.5h, 1 μg/ml calcein was added and the cells were incubated for another 30 min. Dead cells were subsequently stained with 5 μg/ml DAPI for 5 min. For immununofluorescence analysis, cells were washed with ECGM and immediately examined by fluorescence microscopy. The percentage of vital cells was determined by counting dead cells in three randomly chosen microscopic fields. These cells were referred to the total number of fixed cells (see above) which was detected under the different culture conditions and at the different time points. Experiments were performed three times in duplicate.
EC proliferation
Proliferating EC were detected after one day, using a "5-bromo-2'-deoxyuridine (BrdU) Cell Labeling and Detection Kit I" purchased from Roche (Mannheim, Germany). The procedure was performed according to manufacturer's recommendations. BrdU-positive and DAPI-stained cell nuclei were counted in three randomly chosen microscopic fields with the ImageJ software program and the results are stated as percent proliferating cells. Experiments were performed three times in duplicate.
Migration and chemoinvasion assay
Transwell polycarbonate plates with 6.5 mm diameter tissue culture inserts containing a membrane with 8 μm pores (Corning, Wiesbaden, Germany) were coated with 100 μl AG, 100 μl AG + gelatin or 100 μl 5 mg/ml Matrigel TM (see Fig. 5A ). Because Matrigel TM is highly liquid before solidification, less volume loss was observed B Scholz et al. Angiogenesis suppression in hydrogel during pipetting resulting in a slightly increased thickness of Matrigel TM -coating as compared to the more viscous AG-solution. To analyze the migratory potential of the utilized EC in parallel, uncoated transwell inserts were used as control. Bisbenzimide-stained (Hoechst, Frankfurt, Germany) HUVEC (3 x 10 4 cells) were seeded onto the inserts and allowed to settle down for 2h. Then inserts were transferred into new 24 wells containing 600 μl ECGM with or without 40 ng/ml VEGF. After 24h incubation at 37°C and 5% CO 2 , the top sides of the filters were cleansed with cotton swabs soaked in PBS. The membranes were fixed in 4% paraformaldehyde (PFA) for 10 min at room temperature (RT). Afterwards the inserts were rinsed with PBS. For microscopic analysis the inserts were kept in 24 well plates containing PBS. Cell nuclei on the lower side of the membranes were counted in three randomly chosen microscopic fields using ImageJ software. Experiments were performed three times in duplicate and results are indicated as number of cells/filter. Non-stained cells were utilized for qualitative evaluations. After cleansing the upper side of the membrane, the inserts were transferred to 1% Rose Bengal dye in 30% ethanol, rinsed with PBS, mounted on glass slides with fluorescence mounting medium (DAKO, DK) and documented with a microscope VEGF ELISA VEGF expression of chondrocytes from six patients suffering OA cultured for five days within the AG was determined using an anti-VEGF Enzyme-linked Immunosorbent Assay (ELISA) purchased from R&D Systems (VEGF Quantikine System, WiesbadenNordenstadt, Germany). For determination of the total amount of VEGF released into the medium supernatant, the assay was performed according to manufacturer's instructions. Samples were analysed in duplicate. Optical density was measured at 450 nm using a PHERAstar spectrophotometer (BMG LABTECH GmbH, Offenburg, Germany). Wavelength correction was set to 570 nm.
Cytotoxicity Assay
The cytotoxic effect of medium, which was incubated with the AG, on HUVEC and articular chondrocytes was determined. 5 x 10 4 HUVEC were cultured in gelatincoated 96 well plates and 5 x 10 4 chondrocytes were cultured in uncoated 96 well plates. After 24h, cell culture medium was replaced by test medium, which was generated by incubation of 200 mg AG, AG + gelatin and 10 mg/ml Matrigel TM with 1 ml cell culture medium for 24h at 37°C under permanent agitating. Dimethyl sulphoxide (DMSO) served as negative control. Alamar Blue assay was performed after another 24h. Cells were incubated with 10 μg/ml resazurin for 4h (O'Brien et al., 2000) . Fluorescence intensity was measured using a Fluostar OPTIMA spectrophotometer (BMG LABTECH, Offenburg, Germany) with excitation and emission set to 570 and 585 nm, respectively. The results are indicated as percent viability relative to the medium-treated control (100% viability). Experiments were performed six times in triplicate.
Gene expression analysis
The AG was digested with proteinase K (3 mg/ml) for about 10 min at 37°C, the digest was centrifuged and the cell pellet was directly lysed in RLT-buffer (Qiagen, Hilden, Germany). Total RNA was extracted using the RNeasy mini kit plus DNase I digestion according to manufacturer's instructions (Qiagen). Complementary DNA (cDNA) was obtained by reverse transcription of 1 μg total RNA using the Reverse Transcriptase Core kit (Eurogentec, Cologne, Germany) with EuroScript reverse transcriptase (Moloney Murine Leukemia Virus reverse transcriptase, 50 U/μl) and oligo-dT primers. Reverse transcription was performed in a total volume of 50 μl at 48°C for 30 min in a thermocycler (Whatman Biometra, Göttingen, Germany). Gene expression was analyzed by quantitative real-time PCR using an Applied Biosystems (Darmstadt, Germany) 7500 Fast Real-Time PCR System. The qPCR mastermix plus SYBR green I (low ROX) kit from Eurogentec was used. To approximately 1 ng of cDNA, 100-300 mM primers (according to the optimal condition for each primer) and the 2 x reaction buffer were added to a total volume of 25 μl. Primers were designed with the primer express 2.0 software (Applied Biosciences), except primers for collagen type II (Col2A1) (Hengstler et al., 2003) , and were obtained from BIOTEZ (Berlin, Germany). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene. The PCR reaction was started with an initial enzyme activation step at 95°C for 10 min (hot start), followed by 40 cycles of 95°C for 15 sec, 60°C for 30 sec, and 72°C for 30 sec. A melting curve was generated after the last cycle. Threshold levels (Ct values) were determined using Sequence Detection System software (Applied Biosystems). Ct value of the housekeeping gene was subtracted from the Ct value of the genes of interest (ΔCt) and relative expression depicted as 2 -ΔCt .
Chorioallantoic membrane (CAM) assay
Fertilized Hisex brown chicken eggs were incubated at 37°C and 60% humidity. After two days of incubation, 2 ml albumen were aspirated from the eggs. A window was cut into the egg shell and sealed with a Petri dish lid and silicone paste before the eggs were returned to the incubator (Dreesmann et al., 2007) . At day eight (Fig. 6A) of incubation, 200 μl AG, AG + gelatin, AG + VEGF (40 ng/ ml) and AG + articular chondrocytes (2 x 10 5 cells) were transferred onto the CAM (n = 10). As positive control 7 x 7.5 x 1.5 mm 3 OptiMaix-3D TM (Matricel, Herzogenrath,
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Germany) collagen sponges were placed on top of the CAM (n =10). After further incubation for five days, the CAMs were collected and fixed in 4% PFA overnight at 4°C. Photographs of the CAM were used to determine the orientation of blood vessels in the CAM towards the implant (Fig. 6C ). For the negative control, blood vessel orientation was determined towards a randomly chosen circular area (radius = 5 mm) of the CAM (without implant). Fixed specimens were dehydrated in 30% sucrose for at least 48h, embedded in Tissue Tek (O.C.T. Compound, Sakura, USA) for 24h and cryosectioned.
Subcutaneous implantation (NOD/SCID mice)
All animal experiments were approved by the Committee on Animal Care of the State of Baden-Wurttemberg (Germany). With the aid of a twin-chamber syringe, 1.25 x 10 6 IVD chondrocytes (P 1) enclosed in 250 μl human AG were implanted subcutaneously in the backs of nonobese diabetic/severe combined immune deficiency (NOD/ SCID) mice (Charles River Laboratories, Sulzberg, Germany) (see arrows Fig. 7A ). Polymerization was achieved in statu nascendi. Two weeks later, the AG was explanted (Fig. 7A insert) , lysed for gene expression analysis (n = 4) or embedded in Tissue Tek, snap-frozen in liquid nitrogen and cryosectioned. As control for gene expression analysis, IVD cells were cultured in monolayers for two weeks (n = 4). Histochemistry 9 and 14 μm cryo sections were stained with haematoxylin and eosin G according to standard protocols. Microscopic analysis was performed using an Axiophot microscope (Carl Zeiss, Oberkochen, Germany). 7 μm cryo sections were permeabilized with 0.2% Triton X-100 for 10 min, blocked with 1% BSA for 30 min and stained with FITClabelled Sambucus nigra agglutinin (SNA, Linaris, Wertheim, Germany) for 1h at RT. Cell nuclei were visualized with DAPI. Immunofluorescence was analyzed and photographed using an Axiovert microscope. Immunohistochemistry 14 μm cryo sections were permeabilized with 0.2% Triton X-100, blocked with 1% BSA/5% serum and incubated with a 1:100 dilution of rabbit anti-von Willebrand factor (vWF) primary antibody (Santa Cruz, Heidelberg, Germany) for 1h at RT. For aggrecan staining 30 μm sections were not permeabilized, blocked with 3% BSA for 30 min and incubated with a 1:40 dilution of mouse anti-aggrecan primary antibody (Acris, Heidelberg, Germany) for 1.5h at RT. Incubation with secondary antibody (1:300, goat anti-rabbit, AlexaFluor @ 488-labeled, Invitrogen, Karlsruhe, Germany; 1:100, goat anti-mouse, Cy3-labeled, Dianova, Hamburg, Germany) was carried out for 1h at RT in the dark. Cell nuclei were visualized with DAPI and immunofluorescence analyzed using an Axiovert microscope.
Statistics
Results are indicated as means ± standard error. Statistical analysis was performed using StatView (SAS Institute Inc., Cary, NC, USA). One-way ANOVA followed by Fisher-PLSD post-hoc analysis was used to determine statistical significance.* indicates significance with p < 0.05, ** indicates significance with p < 0,005, and *** indicates significance with p < 0,001.
Results
Characterization of chondrocytes within the AG Live-dead staining was performed to evaluate articular chondrocyte vitality within the AG. When cultured in monolayers, the chondrocytes adhered to the bottom of the well plate and displayed a fibroblast-like appearance (Fig. 1B and C) . However, when cultured within the AG, the cells showed a round morphology with few cell-cell contacts (Fig 1D and E) . Chondrocytes were distributed in the AG homogeneously, cluster formation of several cells was only rarely observed. 93% of the chondrocytes were vital in monolayers after one and five days of culturing and within the AG after one day, while the relative number of vital cells decreased to 80% after five days within the AG (Fig. 1F) . To rule out cytotoxic effects, chondrocytes were incubated with medium supernatants of the AG for one day. In contrast to treatment with DMSO used as negative control, the AG showed no cytotoxic effect on the chondrocytes (Fig. 1G) .
Characterization of endothelial cells on AG surfaces
The impact of the AG on EC was investigated by culturing EC on top of the AG to analyze cell adhesion, vitality, functionality and proliferation. After one and five days of culture, EC stained with phalloidin displayed the typical cobblestone-morphology on 2D-gelatin-coating ( Fig. 2C  and D) . On Matrigel TM , EC formed capillary-like structures after one day (Fig. 2E) , however a collapse of these capillary-like structures was observed after five days (Fig.  2F) . EC cultured on AG surfaces with or without gelatin augmentation formed aggregates and seemed to barely adhere to the gel surface (Fig. 2G-J) . In some cases spheroids were observed (see arrows in Fig. 2I ). Quantitative determination of cell adhesion was performed by counting cell nuclei under the different culture conditions. The number of cells on gelatin-coating increased from 130% to 340% within five days of culturing (Fig. 2B ) when referred to the number of seeded cells. Cell numbers on different hydrogels were significantly reduced after one day and decreased further within five days (Fig. 2B) . The addition of pro-adhesive (Relou et al., 1998) gelatin to the AG did not lead to an increase in the counted cell number. On Matrigel TM , the adhesion was slightly increased as compared to the AG variants (Fig.  2B) .
Cell vitality of EC was approved by live-dead staining. While almost all cells were vital on 2D-gelatin-coating, the relative amount of vital cells on Matrigel TM decreased from 92% to 72% within five days (Fig. 3A) . The number of vital cells on the AG with (66%) or without gelatin (67%) was significantly reduced after one day as compared to gelatin-coating and Matrigel TM and even decreased after five days to 33% and 40%, respectively (Fig. 3A) . As illustrated in Fig. 3B , no cell death was induced through a B Scholz et al.
Angiogenesis suppression in hydrogel potential cytotoxic effect of the AG. In contrast to DMSO, neither medium supernatants of Matrigel TM nor medium supernatants of the AG and the AG + gelatin caused a decrease in cell viability (Fig. 3B) , proposing the nonadhesive properties rather than a cytotoxic effect of the AG being responsible for the observed cell death. Furthermore, all vital cells were able to take up DiI-Ac-LDL (Fig. 3D, F, H, J) indicating the preservation of EC functionality under all culture conditions. Finally, the proliferation of EC was determined by incorporation of BrdU. The amount of proliferating cells was significantly increased on 2D-gelatin-coating ( Fig. 4A and E) as compared to the different hydrogels (Fig. 4B, D, E) , with Matrigel TM exhibiting the lowest amount ( Fig. 4C and E) of proliferating cells. In summary, it can be stated that the AG is not a permissive substrate for EC.
EC migration and invasion
Invasion of EC through Matrigel
TM -and AG-coated Transwell filters was investigated to further substantiate the non-permissiveness of the AG for EC, whereas migration of EC through uncoated transwell filters was analyzed as internal control.
Rose Bengal stained EC (arrows) at the lower side of the Transwell filters are shown in Fig. 5C -J. Quantitative evaluation of the internal control revealed an increase in migrated cells after VEGF induction ( Fig. 5B ; 250 cells/ filter without VEGF, 1150 cells/filter with VEGF), confirming the principle ability of the utilized EC to respond to VEGF induction. Regarding the invasion of EC through the different hydrogel-coatings, we could show that 570 EC invaded through Matrigel TM , 180 EC through the AG and 300 EC through the AG + gelatin (Fig. 5B) . Although no significant difference was observed between the hydrogels due to high statistical variations, Matrigel TM seemed to be more permissive for EC than the AG with or without gelatin.
Impact of the AG on chick chorioallantoic membrane angiogenesis
Blood vessels in the CAM exhibit an organized branching pattern. High order vessels branch into several lower order vessels, which then again branch into smaller vessels (DeFouw et al., 1989) . Implantation of the AG and the AG + gelatin did not disturb this pattern (data not shown). In contrast, blood vessels seemed to exhibit less branching . Live-dead staining of chondrocytes cultured in monolayers for one day (B) and five days (C) or within the AG for one day (D) and five days (E). Vital cells were stained with calcein (green) and dead cells with propidium iodide (red). In monolayer cultures, chondrocytes spread out and adhered to the bottom of the well plate while chondrocytes within the AG displayed a round morphology. Quantification of chondrocyte vitality (F). Cytotoxicity assay (G). In contrast to DMSO, medium supernatants of the AG showed no cytotoxic effect on chondrocytes. AG = albumin gel, biochem. = biochemical, DMSO = dimethyl sulphoxide, micr. = microscopical, ML = monolayer; *** marks significance to arrowhead with p < 0.001; scale bar 200 μm.
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Angiogenesis suppression in hydrogel points and changed direction abruptly when the AG + VEGF and the AG + chondrocytes were implanted onto the CAM (Fig. 6E and I ). However, in the positive control (OptiMaix-3D TM ) only, blood vessels grew towards the implant in a spoked-wheel pattern (Fig. 6M) . To further determine the angiogenic potential of the implants, the ratio of blood vessels growing in the direction of the implant (a) and centrifugally from the implant (b) was determined (Fig. 6C) , assuming a positive correlation between the ratio a/b and an angiogenic potential. For the AG and the AG + gelatin, the ratio did not differ from the ratio of the negative control (Fig. 6D) . The ratio a/b was significantly increased in the positive control in comparison with all AG variants (Fig. 6D) . Implantation of the AG + VEGF led to a significant increase in the ratio, while the increase was not significant for the AG + chondrocytes (Fig. 6D) . VEGF production in chondrocytes (2 x 10 5 cells) cultured within the AG for five days in vitro varied between 1.2 and 10 ng VEGF (Fig. 6B) , indicating that the angiogenic potential of the AG + chondrocytes was slightly reduced as compared to the AG + VEGF (8 ng VEGF per gel).
Blood vessels in the implants were detected by means of HE-staining and SNA-binding, both of which allowed the detection of blood vessels in the chick CAM (data not shown). No blood vessels were observed in the AG and the AG + gelatin (data not shown). Furthermore, despite the increased angiogenic potential, no blood vessels were found in the AG + VEGF (Fig. 6F and G) and the AG + chondrocytes (Fig. 6J and K) . When chondrocytes were co-implanted, cell nuclei (arrows) were visible within the AG (Fig. 6J and K) . In contrast to the AGs, cell nuclei and blood vessels (arrowheads) were found in the positive control ( Fig. 6N and O) , excluding the possibility that blood vessels or cell nuclei were overlooked in the previous samples.
Characterization of the AG with IVD chondrocytes in the backs of NOD/SCID mice IVD chondrocytes enclosed in the AG were implanted in the backs of NOD/SCID mice to analyze the ingrowth of blood vessels into the AG and the expression of cartilage specific markers by the IVD chondrocytes. Two weeks . In contrast to DMSO, medium supernatants of Matrigel TM , the AG and the AG supplemented gelatin showed no cytotoxic effect on EC. Live-dead staining of EC on 2D-gelatin-coating (C), Matrigel TM (E), the AG (G) and the AG + gelatin (I). Vital cells were stained with calcein (green) and dead cells with DAPI (blue). The number of dead cells increased on the AG and the AG + gelatin as compared to gelatin-coating and Matrigel TM . Uptake of DiI-Ac-LDL of EC cultured on 2D gelatin-coating (D), Matrigel TM (F), the AG (H) and the AG + gelatin (J). All still viable cells were able to incorporate DiI-Ac-LDL. AG = albumin gel, DAPI = 4',6-diamidino-2-phenylindole, DiI-Ac-LDL = acetylated low-density lipoprotein labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate, EC = endothelial cells; */*** marks significance to arrowhead with p < 0.05/0.001; scale bars 200 μm. . The highest number of proliferating cells was observed on gelatin-coating. Quantification of EC proliferation (E). Proliferation was strongly increased on 2D-gelatin coating as compared to the hydrogels. AG = albumin gel, BrdU = 5-bromo-2'-deoxyuridine, EC = endothelial cells; *** marks significance to arrowhead with p < 0.001; arrows mark proliferating cells; scale bar 100 μm, scale bar in insert 30 μm.
Angiogenesis suppression in hydrogel after implantation, blood vessels were evident in the surrounding subcutaneous tissue, but not in the implant (see arrows Fig. 7A insert) . These results were confirmed immunohistochemically. The AG (Fig. 7C, *) was devoid of vWF-positive blood vessels, while blood vessels were detected in the surrounding tissue. In contrast, HE-staining did not reveal blood vessels in the surrounding tissue (Fig.  7B ). Gene expression of the chondrocyte-specific markers aggrecan, collagen type II and collagen type I was analyzed by real-time-PCR after explantation of the AG. As monolayer expansion before implantation into the patient within the AG is obligatory for clinical application, monolayer cultures were analyzed as control. A significant increase in gene expression was observed for all three markers compared with monolayer control (Fig. 7E) , thereby coincidentally approving vitality of the IVD chondrocytes. For aggrecan, expression was also analyzed on the protein level. Aggrecan was found at the periphery of the AG, but to a lesser extent in the centre of the AG or in the surrounding tissue (Fig. 7D ).
Discussion
We hypothesized whether a currently developed hydrogel based on cross-linked albumin would suppress adverse angiogenesis while supporting chondrocytes, thus underscoring its utility as a structural component for implantation of chondrocytes to treat traumatic and degenerative skeletal disorders. We were able to show that EC were hardly able to adhere onto the AG and that EC vitality was strongly reduced. In contrast to culturing on 2D-gelatin, almost no proliferating EC were found on the AG. The AG remains soft after polymerization which could be one reason for the decreased adhesive potential of EC on the AG. Many cell types are able to respond to the stiffness of their substrate leading to strongly reduced cell adhesion when cultured on soft substrates (Discher et al., 2005) . At the molecular level, the reduction of substrate stiffness leads to a decrease in focal-adhesion associated proteins in HUVEC (Deroanne et al., 2001) . Furthermore, it has been shown that anchorage-dependent EC undergo cell death when exposed to non-adhesive conditions (Chen et al., 1997; Flusberg et al., 2001; Meredith et al., 1993; Polte et al., 2007) , which is consistent with our observations. Cell proliferation is typically restricted to matrix-attached cells (Ben-Ze'ev et al., 1980; Folkman and Moscona, 1978) , a fact which explains the reduced EC proliferation rates on the AG.
For other applications, the stiffness of the AG could be modulated by increasing the concentrations of maleimide-groups and SH-groups, possibly leading to an increased EC adhesion. However, we did not investigate The ratio a/b was slightly increased for the AG + VEGF and the AG + chondrocytes and strongly increased for the positive control OptiMaix-3D
TM as compared to the negative control, the AG and the AG + gelatin. Explanted CAMs with the AG + VEGF (E), the AG + chondrocytes (I) and the positive control OptiMaix-3D TM (M). In the positive control only, blood vessels grew towards the implant in a spoked-wheel pattern. HE-staining of the CAM with the AG + VEGF (F), the AG + chondrocytes (J) and the positive control (N). EC-specific SNA-staining and corresponding phase contrast images of the CAM with the AG + VEGF (G, H), the AG + chondrocytes (K, L) and the positive control (O, P). Blood vessels were only found in the positive control. AG = albumin gel, CAM = chorioallantoic membrane, chondr. = chondrocytes, ctrl = control, HE = hematoxylin eosin, impl. = implant, p = patient, SNA = sambucus nigra agglutinin, VEGF = vascular endothelial growth factor; */*** marks significance to arrowhead with p < 0.05/0.001 (D); * marks the implant (C, E-P), arrows mark cell nuclei, arrow heads mark blood vessels in the implant (N, O) ; scale bars 200 μm.
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this aspect in the current study as our main goal was to investigate the impact of an already approved hydrogel, which has been optimized for the regeneration of articular cartilage and the IVD, on angiogenesis. During angiogenesis, EC emigrate from destabilized blood vessels to form new sprouts (Carmeliet, 2003; Soker et al., 2000) representing an important step in angiogenesis. For this reason, we wanted to investigate the ability of EC to transmigrate through the AG. The Matrigel TM chemoinvasion assay, which had been employed to analyze the invasive potential of EC and tumour cells through basement membranes (Albini, 1998) , was used for analysis. As the change between the unstimulated control and VEGF induction appeared to be comparable under all conditions, VEGF seemed to be able to diffuse through both the Matrigel TM -and the AG-coating in a similar fashion. However, compared to Matrigel TM , EC were hardly able to penetrate the AG. Presumably, the non-adhesive properties of the AG were causal for the inability of EC to invade through the AG.
The results of the chemoinvasion assay gave a first hint that the AG could possibly represent a barrier for blood vessels in vivo. To confirm this assumption we analyzed the ingrowth of blood vessels into the AG by performing two additional in vivo assays: implantation of AG, a) onto the chick CAM (Dreesmann et al., 2007; Norrby, 2006; Ribatti et al., 2001) and, b) into the subcutaneous space of NOD/SCID mice (Stoop et al., 2007) . No blood vessel formation within the pure AG was observed in in ovo CAM assays. To exclude that EC ingrowth might be dependent on chemoattraction (Ferrara et al., 2003) , VEGF additionally was implemented into the gel, as VEGF is synthesized by chondrocytes in osteoarthritis (Enomoto et al., 2003; Honorati et al., 2007; Murata et al., 2008) . Neither recombinant VEGF nor encapsulated chondrocytes (which also produced significant amounts of VEGF) within the AG were able to induce endothelial infiltration. One possible limitation of the CAM assay is the pre-existence of blood vessels on the day of implantation hampering the distinction between these vessels and neovascularisation (Ribatti et al., 1996; Ribatti et al., 2001) . To overcome this limitation we also analyzed the CAM without implants as negative control to obtain a baseline value for preexisting blood vessels. Another limitation is the fact, that the CAM is an embryonic tissue exhibiting exaggerating angiogenesis. However, in this case, we consider this fact to be advantageous. As the AG is able to be a barrier for blood vessels in this highly active tissue, it also promises to inhibit the ingrowth of blood vessels in degenerating cartilage. The AG including IVD chondrocytes implanted in the backs of NOD/SCID mice remained devoid of blood vessels after two weeks post implantation. Since VEGF was found in herniated discs, most likely expressed by IVD chondrocytes (Tolonen et al., 1997) , we assume that the IVD chondrocytes utilized in our experiments also expressed VEGF. Taking all points in account, the AG displayed a barrier function for angiogenic EC in two different in vivo experiments. Immunohistochemical staining of vWF (C). The implant was devoid of blood vessels, while vWF-positive blood vessels were found in the surrounding tissue. Immunohistochemical staining of aggrecan (D). Aggrecan was found in the implant but not in the surrounding tissue. Gene expression analysis of the IVD chondrocytes after explantation. The results are depicted as relative expression in comparison to GAPDH. Gene expression of aggrecan, collagen type II and type I were increased as compared to monolayer controls. AG = albumin gel, col = collagen, GAPDH = glyceraldehyde-3-phosphate dehydrogenase, HE = hematoxylin eosin, ML = monolayer, NOD/SCID = non-obese diabetic/severe combined immune deficiency, vWF = von Willebrand factor; */** marks significance with p < 0.05/ 0.01 (E); * marks the implant (A insert, B-D), arrows mark the site of implantation; lines in B, C and D mark the border between implant and the surrounding tissue; scale bars 100 μm.
The strict non-permissiveness of the AG for EC questioned whether chondrocytes to be co-transplanted in a clinical setting might deteriorate in the AG. Our data substantiated chondrocyte vitality within the AG for extended periods. In contrast to EC, chondrocytes are not anchorage-dependent (Archer et al., 1982; Benya and Shaffer, 1982) . In native articular cartilage, chondrocytes display a round morphology without cell-cell contacts (Archer and Francis-West, 2003) , very similar to what we observed in our approach. In addition, the state of chondrocyte differentiation appeared to follow cell-type specific gene expression. After two weeks of implantation in NOD/SCID mice, the IVD chondrocytes within the AG expressed the cartilage-specific markers aggrecan, collagen type I and collagen type II in a similar fashion as in vivo (Gottschalk et al., 2001) . These data are consistent with earlier reports indicating that the ECM production in chondrocytes is increased under non-adhesive conditions (Archer et al., 1982) . Consequently, the non-adhesive properties of the AG might even be beneficial for chondrocyte metabolic activity.
We were able to show by two control experiments that articular and IVD chondrocytes were vital within the AG and expressed cartilage specific markers. By contrast, the AG was non-permissive for EC as shown in five different in vitro and in vivo assays. In this study we identified further features of the AG, namely barrier properties for blood vessels. As angiogenesis is involved in the progression of degenerative cartilage diseases, this feature could contribute to the regeneration of degenerated cartilage tissue after the implantation of autologous chondrocytes.
